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Recognition and Regulation 
of T Cells by NK Cells
Katharina Pallmer and Annette Oxenius*
Institute of Microbiology, ETH Zürich, Zürich, Switzerland
Regulation of T cell responses by innate lymphoid cells (ILCs) is increasingly documented 
and studied. Direct or indirect crosstalk between ILCs and T cells early during and after 
T cell activation can affect their differentiation, polarization, and survival. Natural killer 
(NK) cells that belong to the ILC1 group were initially described for their function in 
recognizing and eliminating “altered self” and as source of early inflammatory cytokines, 
most notably type II interferon. Using signals conveyed by various germ-line encoded 
activating and inhibitory receptors, NK cells are geared to sense sudden cellular 
changes that can be caused by infection events, malignant transformation, or cellular 
stress responses. T cells, when activated by TCR engagement (signal 1), costimulation 
( signal 2), and cytokines (signal 3), commit to a number of cellular alterations, including 
entry into rapid cell cycling, metabolic changes, and acquisition of effector functions. 
These abrupt changes may alert NK cells, and T cells might thereby expose themselves 
as NK cell targets. Here, we review how activated T  cells can be recognized and 
regulated by NK cells and what consequences such regulation bears for T cell immunity 
in the context of vaccination, infection, or autoimmunity. Conversely, we will discuss 
mechanisms by which activated T cells protect themselves against NK cell attack and 
outline the significance of this safeguard mechanism.
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NK CeLLS: ReGULATiON, eFFeCTOR FUNCTiONS, 
AND eDUCATiON
Natural killer (NK) cells, presenting at a frequency of around 5% in the blood, belong to the family 
of group 1 innate lymphocytes (ILC1) and are functionally characterized by their cytotoxicity and 
their ability to produce cytokines, most prominently interferon γ (IFNγ). NK cells belong to the 
innate immune system, and they can react to rapid changes in host cells without prior sensitization. 
As part of the first line defense, they recognize and lyse virally infected cells and tumor cells. NK 
cells are activated via innate cytokines such as IL-2, IL-12, IL-15, IL-18, and type I IFNs as well 
as via the recognition of sudden cellular changes perceived via different inhibitory and activating 
receptors expressed on their surface (1–7). Additionally, direct triggering of toll-like receptors 
(TLRs) on NK cells can further stimulate their activation (8–10).
Regulation of NK Cell Activity
Compared with T  and B cells whose antigen receptors are highly variable and specific for a 
specific antigen, NK cells express various germ-line encoded activating and inhibitory receptors. 
Depending on the net balance of signals perceived by activating and inhibitory receptors, NK cells 
are either activated and exert effector functions or are restrained (11, 12).
TABLe 1 | viral-derived ligands for NK cell receptors.
Receptor Ligand Source effect of 
ligand/
receptor 
interaction
Reference
NKp46 Viral HA 
and NA
Influenza virus, 
Poxvirus, Sendai 
virus, Newcastle 
disease virus
Activating (31, 145–147)
NKp44 Viral HA 
and NA
Influenza virus, 
Sendai virus, 
Newcastle 
disease virus
Activating (146, 148)
NKp30 Viral HA Poxvirus Inhibitory (147)
pp65 HCMV Inhibitory (149)
TLR7/8 Single-
stranded 
RNA
HIV Activating (150)
Ly49H m157 MCMV Activating (32)
KIR3DL1 NS-1 DENV Activating (151)
HA, hemagglutinin; NA, neuraminidase; NS-1, non-structural protein 1; HCMV, 
human Cytomegalovirus; HIV, human immunodeficiency virus; MCMV, murine 
Cytomegalovirus; DENV, dengue virus.
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Healthy cells constitutively express ligands for inhibitory 
receptors on NK cells in order to protect themselves against 
NK-mediated killing. Classical MHC-I molecules are expressed 
on every nucleated cell in the body and bind to the inhibitory 
receptor killer immunoglobulin-like receptors (KIRs) in humans 
and Ly49A C, D in mice, respectively. The non-classical MHC-I 
molecule HLA-E in humans and Qa-1 in mice binds to the het-
erodimeric inhibitory receptor CD94/NKG2A and CD48 binds 
to the inhibitory receptor 2B4, leading to a repressed state of the 
NK cell (13, 14).
Infected or malignant cells can downregulate MHC-I, also 
known as “missing-self hypothesis,” to become invisible for CD8 
T cells; however, the loss of MHC-I ligands for inhibitory recep-
tors on NK cells sensitizes these cells for NK-mediated killing. 
Conversely, overexpression of ligands engaging NK-activating 
receptors (“induced self-recognition”) also renders these cells 
NK cell targets (14, 15). Activating ligands are not expressed at 
steady-state, but tumorigenesis, virus infection, or DNA damage 
can activate stress pathways, leading to upregulation of various 
activating ligands that bind to NK cell-activating receptors and 
thereby promote NK cell activation, resulting in cytotoxicity 
and cytokine secretion (16). NKG2D is a well-studied NK cell- 
activating receptor, it has multiple cellular ligands including 
MHC-I homologs such as MHC class I chain-related proteins A 
and B (MICA and MICB) and UL16-binding proteins (ULBPs) 
(17). As a result of the activation of heat-shock transcription 
elements in the promoters of the genes, MICA and MICB are 
upregulated on NK target cells. The sensing of type I IFN can 
also trigger MICA and MICB expression on dendritic cells (DCs) 
(18, 19). Moreover, HCMV-infected cells upregulate MICA and 
ULBP3 (20, 21).
The DNAX accessory molecule-1 (DNAM-1 or CD226) is an 
adhesion molecule, which is expressed on multiple cells includ-
ing NK cells. DNAM-1 serves as an activating receptor on NK 
cells, the engagement by its ligands poliovirus receptor (PVR), 
and nectin-2 leads to increased cytotoxicity in NK cells (22, 23). 
The cellular ligands of DNAM-1 are induced upon cellular stress 
(24, 25). Interestingly, regulatory T  cells (Tregs) can also use 
DNAM-1–DNAM-1L interaction to modulate T cell responses, 
indicating that some receptors shared by innate and adaptive 
immunity are involved in regulating T cell responses (26).
Another family of NK cell-activating receptor is the natural 
cytotoxicity receptor family, consisting of NKp30, NKp44, and 
NKp46 in humans. Of note, NCR1 is the NKp46 ortholog and the 
only member of the NCR family in rodents (27). NKp30 and 
NKp46 are expressed on resting NK cells in contrast to NKp44 
which is found only on activated NK cells. Cellular ligands for 
NKp44 are partly known and include proliferating cell nuclear 
antigen (PCNA) and mixed lineage leukemia 5 (MML5). Ligands 
which bind to NKp30 comprise HLA-B-associated transcript 3 
(BAT 3) and B7-H6 (member of the B7 family of immunorecep-
tors) (28). However, the cellular ligands for NKp46 remain elusive 
(29, 30). Activating NK cell receptors may also directly be trig-
gered by microbial constituents, such as Ly49H in C57BL/6 mice, 
recognizing the murine Cytomegalovirus (MCMV) encoded pro-
tein m157 and NCR1 recognizing influenza virus hemagglutinin 
proteins (31, 32) (Table 1).
The fact that ligands for activating NK cell receptors are 
 regulated via stress pathways and that microorganisms have 
evolved mechanisms to downregulate ligands for specific activat-
ing receptors might explain why there are different ligands for 
one receptor (33).
effector Functions
Key effector functions of NK cells comprise cytokine secretion and 
cytolytic granule-mediated cell apoptosis. The secretion of IFNγ 
and tumor necrosis factor (TNF) by NK cells promotes APC and 
phagocyte function, including enhanced phagocytosis, produc-
tion of antimicrobial peptides, oxidative burst, and upregulation 
of MHC molecules. The granule exocytosis pathway is activated 
by the net balance of activation/inhibition signals conveyed by 
inhibitory and activating receptors and involves the secretion of 
granules which contain perforin and granzymes (16). Perforin/
granzyme A and B trigger caspase-dependent and -independent 
death pathways. FasL and TRAIL are expressed on the surface 
of NK cells, which bind to the death receptors Fas (CD95) and 
TRAILR (DR4 and DR5), respectively. The engagement of 
FasL–Fas/TRAIL–TRAILR results in the induction of apoptosis 
of virally infected cells or tumor cells. Antibody-dependent cel-
lular cytotoxicity (ADCC) can be exerted by NK cells when target 
cells are coated with IgG antibodies that bind the Fcγ receptor 
CD16 on NK cells, overriding inhibitory signals and triggering 
cytotoxicity and cytokine secretion (16, 34, 35).
education
As NK cells recognize mostly cellular ligands via their activating 
receptors, NK cells are potentially able to induce tissue damage. 
Thus, a tight regulation is required to avoid self-induced dam-
age by NK cells. To this end, NK cells undergo a process called 
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education, or “licensing,” describing a phase of NK maturation 
in which NK cells acquire effector functions and, at the same 
time, adapt their responsiveness to the steady-state expression 
levels of NK receptor ligands in host cells. For instance, mature 
NK cells recognize MHC-I molecules on the cell surface via their 
inhibitory receptors, resulting in a suppressed state of the NK cell 
toward healthy host cells (36). Surprisingly, the absence of MHC-I 
during NK cell education does not provoke overt NK cell activity, 
but NK cells appear to be hyporesponsive upon stimulation and 
fail to eliminate cells lacking MHC-I. This demonstrates that 
the environment, in which the NK education occurs, effectively 
determines the responsiveness of NK cells [(37, 38) and reviewed 
in Ref. (39)].
Interestingly, NK cells are not only killer cells as part of the 
first line defense but they also have the capacity to shape adaptive 
immunity by regulating T cell responses (40, 41). Of note, NK 
cells are not the only ILCs which are capable of modulating T cell 
responses. There is emerging evidence that other ILC subsets 
can contribute to shape T  cell immunity, either by enhancing 
or suppressing the size of T cell immunity or by regulating the 
differentiation of T  cell responses which was reviewed in Ref. 
(42, 43). In this review, we illustrate how specifically NK cells 
can regulate T  cell immunity from a “T  cell centric” point of 
view, and we will provide further insights into the relevance of 
NK–T cell interaction in various disease settings. In particular, we 
elucidate the role of NK–T cell interaction in acute and chronic 
viral  infections. The profound understanding on how NK–T cell 
interaction occurs in different stages of T cell activation in differ-
ent disease settings, and how it affects the size and quality of T cell 
responses might open new perspectives on the development of 
specific and powerful therapies.
STAGeS iN THe LiFe OF A T CeLL
T  cells need to perceive three signals for proper activation: 
antigen, costimulation, and cytokines. Antigen is processed and 
presented in the context of MHC class I and MHC class II mol-
ecules by APCs and determines the specificity of the response. 
Activated APCs provide further costimulation and cytokines, 
both needed for T cell activation. Among APCs, DCs that have 
been activated by engagement of pattern recognition recep-
tors (PRRs) potently stimulate naive T cells (44). The signal of 
costimulation is provided by a number of molecules including 
CD28–CD80/86, CD27–CD70, OX40L–OX40, 4-1BB–4-1BBL, 
and RANK–RANKL (45–49). The specific cytokines required for 
T cell activation (i.e., proliferation, differentiation, and survival) 
result from the inflammatory milieu triggered by an infection 
or vaccination. In case of viral infections, most prominent pro-
inflammatory cytokines are type I IFNs and IL-12, which have 
redundant functions as signal 3 cytokines (50). Integration of all 
three signals leads to fast T cell proliferation, known as clonal 
burst, reaching peak expansion before contraction and formation 
of a pool of memory cells.
At the peak of T cell expansion, T cells predominantly exhibit 
an effector phenotype (51, 52). Effector CD8 T cells can be split 
into two main subsets, a smaller subset of memory precur-
sor effector cells (MPECs) that have the potential to become 
long-lived memory cells and short-lived effector cells (SLECs) 
that lack this ability (53).
impact of NK Cells on T Cells during 
Priming Phase
At steady-state conditions, NK cells are mainly excluded from 
the LN (54, 55). However, early during infections activated NK 
cells can enter into LN and localize in close proximity to T cells 
in the LN, enabling them to influence T cells during early stages 
of activation and thereby shaping the ensuing size and quality 
of the T cell responses. NK cells circulate in blood and migrate 
in a CXCR3-dependent, but CCR7-independent manner into 
activated LNs (56).
Since APCs are essential for cell activation, any changes in APC 
activation, maturation, and function are tightly associated with 
the emerging T cell response. Although NK cells were also shown 
to directly interact with T cells, this direct interaction seems to 
become more important after initial activation of the T  cells. 
During the initial priming phase, T cell regulation by NK cells is 
mainly occurring in an indirect manner via modulation of APCs.
In the following section, we will elaborate in detail the different 
mechanisms of how DC–NK crosstalk influences the emerging T 
cell response.
NK Cells Promoting T Cell Immunity
Natural killer cells can be beneficial for mounting a T cell response 
by modulating DC function. NK cells act by different mechanisms 
depending on the DC subsets and the prevailing cytokine envi-
ronment. In contrast to immature DCs (iDCs), which are found 
at steady state in peripheral tissues and in the blood, mature DCs 
(mDCs) migrate to the LN in a CCR7-dependent manner and 
have the ability to potently stimulate naive T cells. The conversion 
from iDCs to mDC occurs via sensing PAMPs via PRRs (57). 
mDCs are characterized by high level expression of costimulatory 
molecules, e.g., CD80, CD83, CD86, and MHC class II/human 
leukocyte antigen-DR (HLA-DR), as well by the secretion of pro-
inflammatory cytokines such as IL-12 (58). To reveal interactions 
between DCs and NK cells at the early T cell priming phase, most 
studies with human cells used monocyte-derived DCs. iDCs are 
obtained by culturing monocytes in the presence of granulocyte 
macrophage colony-stimulating factor (GM-CSF) and IL-4. DC 
maturation is induced by the addition of LPS, IL-1, type I IFN, 
or TNF (59).
Human in vitro experiments revealed that DCs promote NK 
cell activity via the secretion of cytokines such as type I IFN, 
IL-12, or TNF. In return, NK/DC interaction leads to NKp30 
engagement, resulting in TNF and IFNγ production by the 
NK cells, which further promotes DC maturation (58, 60, 61). 
Besides cytokines (IL-12, TNF, and IFNγ), mDCs can promote 
IFNγ production, CD69 expression, and cytotoxic functions of 
NK cells in a cell-to-cell contact-dependent manner. Ligands for 
the activating receptor NKG2D on NK cells, MICA and B, are 
expressed on human monocyte-derived DCs and contribute to 
CD69 expression on NK cells (58, 62, 63).
This bidirectional crosstalk can secondarily influence T cell 
differentiation. Specifically, the differentiation of naive CD4 
T cells into IFNγ secreting TH1 T cells is promoted by NK cells, 
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shown by transwell experiments in vitro using human myeloid 
blood DCs (64). Similarly, NK cells can also directly shape, pos-
sibly without direct DC crosstalk, the quality of T cell responses 
via their cytokine secretion. A murine in vivo study demonstrated 
that after activated NK cells migrated to the LN in a CXCR3-
dependent manner where they served as an early source of IFNγ 
that was essential for Th1 polarization of naive CD4 T cells (56). 
In a mouse model of Leishmania major infection, the blockade 
of TGFβ signaling in NK cells led to increased IFNγ secretion by 
NK cells, promoting the differentiation of naive CD4 T cells into 
Th1 cells, leading to improved pathogen control (65).
Another mechanism how NK cells indirectly influence the 
emerging T cell response during the priming phase of T cells via 
enhancing cross-presentation. NK cells promote DC cross-pres-
entation by killing target cells, leading to the release of antigens 
that can be taken up by DCs and presented via MHC-I to T cells, 
resulting in an increased CD8 T cell response. Specifically, trans-
fer of allogenic B cells in mice resulted in NK-mediated killing 
that promoted endocytosis of apoptotic bodies by CD8+ DCs and 
MHC I presentation of respective antigens (66). Similarly, in vivo 
killing of OVA-expressing splenocytes by NK cells resulted in bet-
ter priming of CD8 as well as CD4 T cells due to NK-mediated 
release of antigen. Here, NK-mediated cytotoxicity promoted 
CD4 T cell responses, which was crucial to support CD8 T cell 
responses and strong IgG responses (67). Also in human cells, NK 
cell-secreted IFNγ and TNF induce cross-presentation of tumor 
cell-derived antigens by monocyte-derived DCs, promoting the 
induction of a tumor-specific CD8 T cell response (68).
Several studies have reported that activated NK cells specifi-
cally kill iDCs, while sparing mDCs. Albeit the direct killing of 
iDC might have a negative impact on the emerging T  cell 
response, it is more likely that the killing of iDCs might be 
beneficial for robust T cell immunity. This DC selection, known 
as DC editing, might serve as a quality control to guarantee the 
survival of DCs expressing sufficient costimulation molecules 
needed for successful T cell priming or to ensure that effective 
T cell priming is stopped after resolution of infection-induced 
inflammation (61, 69).
Human NK cells, activated with IL-2 in  vitro, killed, and 
produced IFNγ when encountering iDCs. In contrast, lysis of 
mDCs occurred only when inhibitory ligands (HLA molecules) 
were blocked, showing that mDCs protect themselves against NK 
cell attack by KIR engagement. NKp30 engagement was mainly 
responsible for detection and elimination of iDCs. However, 
NKp30 was also shown to induce maturation and favor DC 
activation, and it is currently unclear how this differential role 
of NKp30 in NK cells is regulated (28, 69). The in vitro finding 
that human iDCs are preferably lysed by NK cells was confirmed 
in a tumor mouse model in vivo. Impaired tumor-specific T cell 
immunity was related to the missing deletion of iDCs in the 
absence of NK cells (70). NK cells can kill iDCs due to lacking 
expression of the inhibitory ligand Qa-1 in contrast to mDCs 
that upregulate its expression. Interestingly, iDCs were also killed 
under inflammatory conditions (71).
By contrary, it was also reported that iDCs can promote 
T cell immunity: in a DC-based vaccine model in mice preven-
tion of TRAIL-mediated iDC killing by NK cells enhanced 
antigen-specific T cell responses (72). However, these studies 
relied on adoptive transfer of in vitro cultivated DCs (LPS treated, 
mature, monocyte-derived DCs and untreated, immature, DCs). 
To what extent these in  vitro cultivated iDCs resemble in  vivo 
iDCs remains to be demonstrated (69, 73).
In summary, NK cells improve maturation, effector functions, 
and cross-presentation of DCs and are thereby able to promote 
T cell responses. Moreover, NK cells can secrete cytokines during 
T cell priming, which promote the differentiation of naive CD4 
T cells to Th1 cells. The elimination of iDCs might be a possible 
control mechanism to select immunogenic DC, which provide 
sufficient costimulation needed for the effective stimulation of 
naive T cells (Figure 1).
NK Cells Impairing T Cell Immunity
Negative impact of NK cell on T  cells during priming can be 
either mediated by directly affecting T cells or indirectly via DC 
modulation.
Even though killing of iDCs might have a positive effect on 
T  cell priming, direct killing of mature APCs, especially DCs, 
results in diminished antigen availability and thereby represents a 
mechanism how NK cells can negatively regulate T cell responses.
An in vivo mouse study revealed that in the absence of NK cells 
APCs show improved capacity to stimulate CD8, but not CD4 
T  cells early during LCMV infection and this enhanced virus-
specific CD8 T cell response resulted in viral clearance of a usually 
persistent infection. The beneficial effects could only be observed 
when NK cells were depleted within first 2 days of infection and 
were not due to enhanced costimulation provided by APCs, but 
most likely due to increased numbers of APCs in NK cell-depleted 
mice (74). In the context of MCMV infection in C57BL/6 mice, 
the MCMV protein m157, that is directly recognized by L49H 
on NK cells, triggered NK-mediated killing of MCMV-infected 
DCs. The resulting lower numbers of antigen-presenting DCs in 
this setting translated into impaired T cell immunity and hence 
protracted lytic replication (75). Furthermore, in MCMV infec-
tion, proinflammatory cytokines, such as IL-12, IFNγ, and TNF, 
and NK cell-activating receptors, such as NKG2D and NCR1, 
were shown to promote a bidirectional NK/DC crosstalk that 
supported CD4 T cell priming. Interestingly, IL-10 negatively 
regulated this crosstalk, such that only in absence of IL-10, NK 
cells supported DCs to more effectively prime MCMV-specific 
CD4 T cells, resulting in enhanced virus control (76).
In vitro- and in  vivo-activated murine NK cells can acquire 
MHC-II proteins from interacting DCs via membrane transfer 
in a process known as trogocytosis. However, MHC-II- and 
costimulatory molecule-expressing NK cells did not promote but 
rather inhibited proliferation of CD4 T cells in presence of DCs, 
suggesting that they competed with antigen-presenting DCs for 
engagement of CD4 T cells (77).
In contrast, human MHC-II-expressing NK cells that also 
express costimulatory molecules typical for DCs, such as CD80/
CD86, are capable to induce CD4 T  cell proliferation (78–81). 
Thus, the crosstalk between DCs and NK cells can either support 
or impair initial activation of T cells, raising the question which 
factors decide about the outcome of the interaction. First of all, 
depending on the nature of the cytokines NK cells are exposed 
FiGURe 1 | NK–T cell interaction during early phases of viral infections. 
(Continued)
FiGURe 1 | Continued
Naive T cells (gray) are primed by DCs, expand, and differentiate into effector 
T cells (purple), contract and form memory T cells (red). Activation of NK cells 
and T cells show a temporal and microanatomical overlap early during 
infection allowing T cell regulation by NK cells. (1) Early during infection NK 
cells can directly regulate T cells via the secretion of cytokines. Indirectly, NK 
cells modulate DC numbers and function, which affect T cell responses. The 
bidirectional NK–DC crosstalk is achieved by cytokine secretion or via direct 
cell-to-cell contact, resulting in either positive or negative consequences for 
T cells. (2) Early activated T cells can be recognized and inhibited (green 
shading) or eliminated (red shading) by NK cells via cytokines or directly in a 
cell-to-cell-dependent manner. T cells shield themselves by upregulating 
ligands for inhibitory NK cell receptors (blue shading). Abbreviations: IFNγ, 
interferon γ; TNF, tumor necrosis factor; IL-12, interleukin 12; IL-10, 
interleukin 10; type I IFN, type I interferon; NKp30L and NKp46L, ligands for 
the NK cell-activating natural cytotoxicity receptors; NKp46 and NKp30, NK 
cell-activating natural cytotoxicity receptors; NKG2DL, ligands for activating 
NK cell receptor; NKG2D, activating receptor of NK cells; TRAIL-R2, tumor 
necrosis factor receptor; TRAIL, ligand for tumor necrosis factor receptor; 
CD94/NKG2A, Ly49D, and 2B4, inhibitory NK cell receptors; Qa-1, MHC-I, 
and CD48, inhibitory receptor ligands; TH1, T helper cell type 1; iDC, 
immature dendritic cell; mDC, mature dendritic cell.
5
Pallmer and Oxenius Recognition and Regulation of T Cells by NK Cells
Frontiers in Immunology | www.frontiersin.org June 2016 | Volume 7 | Article 251
to, they can either promote or inhibit the polarization of T cells. 
While IL-12 and IL-2 can promote the maturation of DCs that 
are capable of priming IFNγ secreting TH1 T  cells, regulatory 
cytokines, such as IL-10, lead to a reduction of the NK–DC cross-
talk and to a decreased priming of virus-specific T cells (76, 82).
Moreover, another decisive parameter is the NK:DC ratio. 
While in a situation of a low NK:DC ratio, NK cells preferentially 
promote DC activation and enhance secretion of cytokines by the 
DCs, a high NK:DC ratio favors NK-mediated killing of autolo-
gous DCs (61). Besides this ratio also the density of receptors on 
the NK cell surface may decide about their impact in shaping 
T cell responses. For example, NK cells that express a high density 
of NCR1 showed an increased cytotoxicity against NK sensitive 
tumor cell lines compared with NK cells expressing lower levels 
of NCR1. However, if the density of activating receptors on NK 
cells is also decisive for their ability to directly kill T cells or APCs 
remains to be investigated (83).
Taken together, NK cells have the potential to regulate T cell 
responses during their priming phase directly via proinflamma-
tory cytokines, such as IFNγ, as well as indirectly by eliminating or 
promoting APCs numbers and function by various mechanisms 
(Figure  1). Future studies are essential to elucidate the factors 
which decide whether NK cells promote DC maturation, leading 
to an enhanced T cell response due to efficient priming of naive 
T cells or whether NK cells eliminate DCs which leads to reduced 
T cell immunity.
early Activation and Clonal expansion
The following paragraph focuses on effector T  cells; how NK 
cells influence Tregs and vice versa is summarized in Box 1. After 
encountering its cognate peptide presented by an APC in presence 
of costimulation and cytokines, a T cell rapidly undergoes clonal 
expansion. NK cells have the ability to recognize and directly kill 
early activated T cells and can thereby determine the quality and 
magnitude of T cell responses, which can influence the course of 
infection (84–90).
BOX 1 | Treg–NK cell interaction.
Regulatory T cells (Tregs) are characterized by the expression of the master 
transcription factor Foxp3 and are able to control effector T cells responses by 
inhibiting innate and adaptive immunity (91). Lately, several studies reported 
that Tregs influence NK cells. In Scurfy mice, that fail to develop Tregs, NK 
cells are hyperproliferative and show enhanced effector functions, hinting 
toward an interaction between Tregs and NK cells – or alternatively, that NK 
cells are activated as a consequence of the increased proinflammatory milieu 
presenting in absence of Tregs (92). Also, under homeostatic conditions, 
Treg depletion results in hyperreactivity of NK cells in terms of CD69 expres-
sion and cytolytic functions and IFNγ secretion (93). In line with increased 
activation in the absence of Tregs, NK cells show an increased missing self-
responsiveness toward target cells and rapidly respond to weak stimulation. 
This hyperactivation depends on high levels of available IL-2 produced by 
CD4 T cells after Treg depletion. Thereby, low levels of IL-2, as in the presence 
of Tregs, can serve as a limiting factor restricting NK cell activity (94). This was 
confirmed in a genetic model of type I diabetes in mice in which Treg depletion 
led to infiltration and proliferation of NK cells in the pancreas, accompanied 
by the secretion of IFNγ that promoted disease progression. In this setting, 
the lack of IL-2 consumption by Tregs led to the elevated levels of IL-2, 
promoting NK cell activity, and was not due to higher numbers of CD4 T cells 
secreting IL-2 (95). Interestingly, upon MCMV infection, the restricting effect of 
Tregs on NK cells was abolished and virus titers between Treg-sufficient and 
Treg-depleted mice were comparable. Thus, the Treg-mediated suppression 
of NK cells might be overridden by availability of high IL-2 levels during viral 
infections (93).
However, in hepatitis C virus (HCV) infection, NK cells were suppressed by 
Tregs, which was shown in a human in vitro study. In HCV, NK cells are known 
to kill activated hepatic stellate cells (HSCs), which promote fibrosis. NK cell-
mediated killing could be inhibited by Tregs in a cell–cell contact-dependent 
manner involving the cytotoxic T lymphocyte antigen 4 (CTLA-4). Interestingly, 
the preincubation of HSCs with Tregs resulted in reduced expression of 
activating ligands, such as MICA/B on HSCs, leading to suppression of NK 
cell effector functions (96). Not only CD4 Tregs interact with NK cells but also 
regulatory DCs (regDCs), which is a special DC subset inducing tolerance 
under certain physiological settings. The interaction between regDCs and NK 
cells induced an alternative activation state in NK cells, characterized by low 
levels of IFNγ secretion. This suppression was attributed to the secretion of 
IL-10 by DCs and, surprisingly, by the engagement of the activating receptor 
NKp46 on NK cells (97). This opposing effect of NKp46 might be due to the 
fact that naive NK cells were used in this DC coculture, while other studies 
used activated NK cells or cocultured NK cells in presence of virus-infected 
DCs (98, 99). Collectively, these studies show that NK cells can be controlled 
reciprocally by regulatory immune cells, in particular by Tregs. This notion 
might be relevant in the setting of diseases in which Tregs are increased, such 
as in chronic viral infections or cancer (100–103).
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In mice, IL-2-activated NK cells specifically detect and kill 
activated CD4 and CD8 T  cells in a perforin-dependent man-
ner. Activated NK cells discriminate between activated and 
naive T cells via the activating receptor NKG2D (84). Similarly, 
human-activated T cells are susceptible to NK-mediated killing 
by upregulating ligands for NKG2D. Furthermore, human T cells 
also upregulate ligands for the activating receptor DNAM-1, such 
as PVR, upon stimulation with superantigen. Only T cells in the 
S and G2/M phases expressed PVR which is in line with the 
fact that NK cells preferentially kill proliferating T  cells (104). 
These human in vitro studies showed that autologous T cells can 
be killed by NK cells via DNAM-1 and NKG2D in a granule 
exocytosis-mediated manner, which might serve as a mechanism 
to control T cell responses (85, 104).
In vivo, the absence of NK cells prevented establishment of a 
chronic LCMV infection in mice (86, 87). Mechanistically, some 
studies suggested that CD8 T cells can be directly killed by NK 
cells in a NKG2D- and perforin-dependent manner, while oth-
ers reported that NK cells killed quite selectively activated CD4 
T cells, which subsequently led to reduced CD8 T cell numbers 
and function. The NK cell-mediated killing of CD4 T  cells 
required perforin; however, the exact mechanism how NK cells 
recognize activated CD4 T cells was not revealed (86, 87, 105). 
The differences in mode of action of NK cells during LCMV 
infection reported in these studies might be based on the use of 
different viral strains and infection doses.
Natural killer cells can regulate T  cells also in a contact-
independent manner via the secretion of IL-10, leading to the 
suppression of allergen and Ag-induced T  cell proliferation 
(106, 107). In LCMV infection, IL-10 secreted by NK cells can 
restrict the magnitude of CD8 T cell responses during persistent 
viral infection and can thereby limit immunopathology (108).
As activated T cells are prone to be recognized and eliminated 
by NK cells, T cells have evolved mechanisms to protect them-
selves against NK-mediated cytolytic attack. One mechanism 
how T  cells can protect themselves is via sensing type I IFN 
because virus-specific CD4 and CD8 T cells deficient for type-I 
interferon receptor (Ifnar) were effectively eliminated by NK 
cells in a perforin-dependent manner upon acute LCMV infec-
tion, demonstrating that sensing of type I IFN-induced specific 
downstream pathways in virus-specific T cells leading to protec-
tion from NK cell recognition and hence promoted survival 
and expansion (89, 90). Indeed, Ifnar-deficient activated T cells 
express ligands for the activating receptor NCR1 on their surface 
and are recognized via NCR1 on NK cells and are killed by the 
release of perforin. Virus-specific wild-type T cells, which were 
able to sense type I IFN, safeguarded themselves and resisted the 
NK cell attack due to absent expression of NCR1 ligands (90).
Interestingly, not only activated T cells need to evade NK cell-
mediated killing but also NK cells themselves. Recently, it was 
reported that Ifnar-deficient NK cells were also killed by activated 
NK cells in a perforin-dependent manner. NK cell killing of Ifnar-
deficient NK cells was not NCR1, but NKG2D dependent (109). 
The independent findings that type I IFN sensing is associated 
with absent expression of NCR1 or NKG2D ligands on the surface 
of different immune cells suggests that type I IFN downstream 
signaling pathways, including STAT 1 signaling, seem to provide 
conserved protective mechanisms of how activated immune cells 
avoid NK-mediated killing. In future studies, it will be important 
to gain a more detailed knowledge about the regulation of expres-
sion of ligands for activating or inhibitory NK cell receptors on 
activated immune cells.
Besides the upregulation of activating ligands on T cells, the 
absence of inhibitory ligands is also a mechanism how T cells can 
be rendered targets for NK cell-mediated lysis early during activa-
tion. On this line, Ifnar-sufficient virus-specific T cells showed 
higher expression levels of classical and non-classical MHC-I 
molecules, ligands for inhibitory NK cell receptors, compared 
with Ifnar-deficient cells (89).
In addition, NLCR5, a transcription modulator promoting 
MHC-I expression, was shown to protect T cells against NK cell 
attack, as NLRC5-deficient T  cells became targets for NK cells 
under inflammatory conditions due to strongly reduced MHC-I 
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expression (110). Furthermore, the absence of the inhibitory 
receptor 2B4 on NK cells was associated with a prolonged per-
sistence of LCMV because virus-specific CD8 T cells were killed 
by NK cells. Even though CD8 T cells expressed high levels of 
MHC-I, they could not shield themselves from NK cell-mediated 
attack, showing that the protective features of MHC-I and CD48 
are non-redundant (111, 112). Of note, 2B4 can act as a coactivat-
ing receptor on human NK cells, in particular, in combination 
with CD16 (113) or in synergy with NKG2D, NKp46, and 
DNAM-1, resulting in enhanced cytotoxicity of naive human NK 
cells (114, 115). However, if 2B4 as a coactivating receptor on NK 
cells impacts on T cell regulation remains to be demonstrated.
Natural killer cells were also shown to diminish the number 
of CD4 TFH cells and thereby to affect B cell responses. During an 
acute LCMV infection, NK cells killed CD4 TFH cells in a perforin-
dependent manner, resulting in a weak germinal center (GC) 
response and reduced titers of virus-specific antibodies (116). 
NK depletion early during a chronic LCMV infection enhanced 
the levels of virus-specific antibodies, thereby contributing to 
control of the infection. Even though the underlying mechanisms 
were not revealed so far, elevated numbers of CD4 TFH cells sug-
gested that NK cells promote viral persistence by suppressing not 
only CD8 T immunity but also CD4 TFH cells and consequently 
humoral immunity (117).
Taken together, NK cells have the potential to shape T cell 
responses early during activation, mostly by curtailing T  cell 
responses and humoral immunity (Figure 1). Why would such 
regulation of T  and B cell responses by NK cells exist? One 
situation in which this regulation has physiological relevance is 
chronic viral infections when NK cell-dependent killing of T cells 
and suppression of T cell functions may prevent T cell driven 
immunopathology. Furthermore, infection with intermediate 
LCMV doses normally leads to detrimental immunopathology 
due to a strong T cell response, which is not sufficiently inhibited 
by NK cells. Depletion of NK cells, in this model, leads to an 
early enhanced T  cell response that mediates control of the 
infection (86).
Finally, NK cells may ensure that only “correctly” activated 
CD8 T  cells, which have received all three activation signals, 
survive. “Incorrectly” activated T  cells (i.e., those that might 
have only perceived one or two signals) might become targets for 
NK cells. This hypothesis originates from the observation that 
LCMV-specific T cells that have not sensed signal 3 (i.e., type I 
IFN) are exquisite targets for NK cells. Such incorrectly activated 
T cell might potentially be harmful for the host, for instance, in 
case of autoreactive T cells. This is, however, at the moment, pure 
speculation that needs to be addressed experimentally.
Contraction and Memory Formation
The peak in the life of a T  cell is around day 8 after antigen 
activation before the population of expanded T  cells contracts 
massively due to apoptosis of antigen-specific effector T cells. The 
decline of T cell numbers is necessary to allow the organism to 
respond to new pathogens and to avoid immunopathology (118). 
NK cells do not seem to be involved in the contraction phase 
because virus-specific T cells decline in NK-depleted mice to the 
same extent as in NK-sufficient mice after acute LCMV infection 
(90, 105). After the contraction phase, few antigen-specific T cells 
differentiate into long-lived memory cells, which are dependent 
on IL-7 and IL-15 for homeostasis (119, 120).
Even though the decision about T cell differentiation occurs 
early during T  cell activation and not during the contraction 
phase, the effects of NK cells on long-term memory formation 
will be discussed briefly. At the peak of T  cell expansion, the 
population of antigen-specific T cell can be divided into SLECs 
and MPECs, with the latter fueling the pool of long-lived 
memory cells. In the absence or presence of NK cells, virus-
specific T cells differentiated into MPECs and SLECs, indicating 
that NK cells do not affect the establishment of both effector 
subpopulations. Hence, establishment of T cell memory occurs 
both in presence and absence of NK cells during the priming 
phase in the context of an acute LCMV infection – albeit total 
numbers of memory cells might be slightly reduced in presence 
of NK cells due to slightly reduced peak expansion (88, 90, 116). 
In mice, the lack of Qa-1 on T cells, which binds to the inhibitory 
receptor CD94/NKG2A on NK cells, led to reduced survival of 
CD4 T  cells. Furthermore, memory formation was drastically 
reduced, suggesting that Qa-1 plays a role in CD4 T cell survival 
and memory development (121). In an OVA vaccination model 
in mice, memory CD8 T  cell responses were increased in the 
absence of NK cells, which was associated with a better control 
of tumor growth (105).
Natural killer–DC interactions not only occur during primary 
immune responses but also during recall responses, which was 
shown in a secondary infection model using different OVA-
expressing pathogens. Upon secondary infection with Listeria 
monocytogenes, memory CD8 T cells were activated by IL-12 and 
CXCL9 secreting XCR1+ DCs, leading to improved reactivation 
of memory CD8 T cells. Upon recall, NK cells were rapidly acti-
vated and provided an early source of IFNγ, boosting XCR1+ DC 
functions, which resulted in a stronger recall CD8 T cell response 
(122).
Collectively, there are some indications that NK cells 
have the potential to shape the differentiation of memory 
T cells –  although such impact may actually take place during 
the priming period – and decide thereby about the quantity of 
memory T cells.
Disease
In the following part, we provide an overview about NK–T cell 
interactions in specific disease settings. In particular, we empha-
size on how NK cells affect T cells during chronic viral infections 
and how chronic viral infections can modulate NK–T cell inter-
action. We also extend the discussion on the role of NK–T cell 
interaction in autoimmune disorders.
Role of NK Cells during Chronic Virus Infections
During chronic active viral infections, “classical” memory T cell 
formation is impaired. Instead, virus-specific CD8 T  cells are 
maintained as a population of actively cycling cells that depends 
on recurrent activation by cognate antigen (123). Functionally, 
the virus-specific CD8 T  cells are markedly impaired in 
their effector functions, predominantly in their ability to 
produce inflammatory cytokines such as IFNγ and TNF. This 
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hypofunctional state is termed “exhaustion,” and its genesis is 
related to recurrent antigen exposure and the expression of a 
number of coinhibitory receptors that downregulate signal 
transduction from the TCR (123). Even though the depletion of 
NK cells early during a chronic LCMV infection leads to morbid-
ity and mortality, due to enhanced antiviral T cell immunity, NK 
depletion 2 or 3 weeks after the peak of cytotoxic CD8 T cells is 
associated with improved antigen-specific CD8 T cell response 
and better virus control and led to only weak immunopathologi-
cal symptoms (86, 124).
In human immunodeficiency virus-1 (HIV-1) infection, NK 
cells are activated and upregulate the activating receptor NKp44, 
while CD4 T cells express a cellular ligand for NKp44 (NKp44L). 
The expression of NKp44L is induced by the HIV-1 envelope 
gp41 protein and renders CD4 T  cells highly susceptible to 
NK-mediated lysis. Interestingly, NKp44L expression was only 
observed in uninfected CD4 T cells. In infected CD4 T cells, the 
HIV-derived protein Nef inhibited the upregulation of NKp44L 
on the surface. Thus, the downregulation of NKp44-activating 
ligands on infected CD4 T cells might serve as an immune escape 
mechanism, while NKp44 ligand expression on non-infected 
CD4 T cells may contribute to the overall depletion of CD4 T cells 
over the course of infection (125). In addition, Nef and the late 
viral factor Vpu induced the downregulation of PVR, which is 
a ligand for the activating receptor DNAM-1 on NK cells. The 
blockade of DNAM-1 and NKG2D together reduced killing of 
HIV-1-infected cells by NK cells, indicating that both DNAM-1 
and NKG2D are involved in the regulation of NK cell recognition 
of HIV-1-infected cells (126). Another study in HIV-1-infected 
patients revealed that plasmacytoid DCs secreted type I IFN 
which induced NK cells to kill HIV-infected CD4 T cells with the 
engagement of NKp46 and NKG2D. In this setting, NK-mediated 
lysis represents an antiviral immune response contributing to 
control the infection (127). Chronic hepatitis B virus (CHB) infec-
tion is also characterized by activated NK cells and a decrease of 
T cell functions or clonal deletion of virus-specific T cells. Studies 
using human samples derived from CHB patients revealed that 
virus-specific CD8 T cells in the liver are NK cell targets as they 
expressed higher levels of TRAIL-R2 which engages TRAIL on 
NK cells, leading to NK-mediated killing. Surprisingly, only HBV-
specific T cells were affected by NK regulation via the TRAIL-R2/
TRAIL pathway, but not other virus-specific T  cells such as 
Epstein–Barr virus (EBV) or Cytomegalovirus (CMV)-specific 
T cells (128). NK cells and T cells derived from CHB patients are 
both functionally impaired. Nucleos(t)ide analog (NUC) therapy 
can improve T- and NK-cell responses and resulted in a reduc-
tion of an inflammatory phenotype of NK cells derived from 
CHB patients, characterized by reduced expression of TRAIL, 
CD38, and Ki-67. The change to a quiescent phenotype in NK 
cells was accompanied by the restoration of effector functions 
of HBV-specific T cells under NUC therapy. NK depletion and 
blockade of TRAIL and NKG2D further ameliorated the HBV-
specific T cell functions (129). These studies clearly demonstrate 
that NK cells play a role in regulating HBV-specific T cells during 
chronic HBV infection. The regulation of HBV-specific T  cells 
by NK cells might be under certain conditions beneficial for the 
host due to diminished immunopathological consequences. The 
complex interplay of NK cells and T cells in CHB was reviewed 
in Ref. (130).
EBV, which belongs to the herpesviridae family, causes a 
persistent latent infection and has a prevalence of over 90% 
in the population. While, in most individuals, the infection 
occurs without symptoms, in around 10% the infection results 
in infectious mononucleosis (IM), which is related to massive 
expansion of EBV-specific CD8 T  cells (131). A study using 
humanized mice for EBV infection presented the hypothesis 
that NK cells could limit T  cell expansion by directly killing 
T  cells and thereby preventing the development of IM. It is 
therefore speculated that EBV seronegative individuals that 
have low numbers of NK cells are more prone to develop IM 
(132).
Natural killer cells are likewise involved in regulating T cell 
responses specific for MCMV, also a member of the herpesviridae 
family. During MCMV infection, NK cells kill activated CD4 
T cells in the salivary gland. The elimination of activated CD4 
T  cells was dependent on TRAIL and led to a prolongation of 
the lytic virus replication; however, it prevented virus-induced 
autoimmunity at the same time (133). This shows that NK cells 
have, indeed, a regulatory role which has the ability to restrict 
strong adaptive immune responses in the setting of persistent 
viral infections (Figure 2).
Role of NK Cells in Autoimmune Disease
Natural killer cells are also involved in regulating autoreactive 
T cells. This was demonstrated in the mouse model for multiple 
sclerosis, experimental autoimmune encephalomyelitis (EAE). 
Depletion of NK cells was associated with a more severe form of 
EAE, characterized by the occurrence of relapses. The exacerba-
tion of the disease was due to increased T cell proliferation and 
cytokine production (134). Besides the TRAIL–TRAILR pathway 
inducing apoptosis in autoreactive T cells, blockade of the Qa-1/
CD94-NKG2A axis led to an amelioration of EAE due to the 
elimination of autoreactive CD4 T cells by NK cells in a perforin-
dependent manner (121, 133).
The human CD56bright NK cell subset is most prominent in 
peripheral lymphoid organs compared with the CD56dim subset 
which mostly circulates. CD56bright cells derived from healthy 
individuals could suppress autologous CD4 T cell proliferation 
under inflammatory conditions via the activation of NCRs and 
the secretion of granzyme. In comparison, CD56bright derived 
from MS patients exhibited reduced granzyme secretion due 
to higher expression levels of the inhibitory ligand HLA-E on 
CD4 T  cells and not due to altered NCR expression on NK 
cells (135). In addition, enrichment of CNS-resident NK cells 
in EAE had beneficial effects on the disease progression by sup-
pressing TH17 cells (136). Paradoxically, the absence of IFNγ 
in a transgenic mouse model led to more severe symptoms in 
EAE, uveitis, and arthritis. In the presence of IFNγ, NK cells 
migrated to the LN where they interacted with DCs promoting 
IL-27 production, leading to the suppression of disease-inducing 
TH17 T  cells and therefore to protection from autoimmunity 
(137). Studies in MS patients revealed that the reduced cytolytic 
functions of NK cells are due to an impaired interaction between 
NK cells and CD4 T  cells via DNAM-1-PVR and 2B4-CD48. 
FiGURe 2 | NK–T cell interaction in chronic virus infections. Naive T 
cells (gray) are primed by DCs, expand, and initially form effector T cells 
(purple) that transition during a chronic infection T cells to “exhausted T cells” 
(blue) due to constant restimulation by cognate antigen. (4b) NK cells 
recognize and eliminate T cells during a chronic state of viral infections by a 
direct cell-to-cell contact. Abbreviations: NKp44L and NKp46L, ligands for 
the NK cell-activating natural cytotoxicity receptors; NKp44 and NKp46, NK 
cell-activating natural cytotoxicity receptors; NKG2DL, ligands for activating 
NK cell receptor; NKG2D, activating receptor of NK cells; TRAIL-R2, tumor 
necrosis factor receptor; TRAIL, ligand for tumor necrosis factor receptor 
superfamily; CHB, chronic hepatitis B virus; MCMV, murine Cytomegalovirus; 
HIV, human immunodeficiency virus.
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Thus, the dysregulation of NK–T  cell interaction in MS may 
present an attractive therapeutic target. Indeed, therapeutic 
immune modulation targeting IL-2Rα (CD25) by daclizumab 
was shown to selectively expand CD56bright NK cells, activate NK 
cell functions, and induced upregulation of PVR on the surface 
of CD4 T cells, rendering these susceptible for NK cell-mediated 
killing (138–140).
The activating receptor NKp46 is known to be associated with 
the induction of type I diabetes. Using knockout mice, in which 
NKp46 is ablated, revealed that these mice are less prone to develop 
diabetes. Mechanistically, NK cells degranulated after binding via 
NKp46 to beta islet cells of the pancreas. The ligand for NKp46 
expressed on beta islet cells is still unknown (141, 142). Whether 
the lack of NKp46 has also influence on autoreactive T cells in 
diabetes type I remains to be shown.
Moreover, NKp46 is also involved in graft-versus-host disease 
(GVHD) because the absence of NKp46 in GVHD led to rapid 
mortality. However, it has remained elusive if NKp46 is needed for 
direct killing of host-reactive T cells, or whether regulation occurs 
indirectly via APCs in the context of GVHD (143). Furthermore, 
NK cells expressing the activating receptor Ly49D rapidly killed 
allogenic DCs in a murine skin transplantation model through 
the release of perforin. The absence of allogenic DCs inhibited 
alloreactive CD8 T cell responses emerging in the draining LN. 
In addition, NK cells could limit alloreactive CD4 T cells via the 
activating receptor Ly49D (144). These studies demonstrate that 
NK cells play a role in GVHD via the activating receptors Ly49D 
and NKp46.
CONCLUDiNG ReMARKS
Even though NK cells are mainly known as killer cells of the innate 
immune system, there is more and more evidence that NK cells 
can shape the adaptive immune system by influencing T cells in 
different stages of their lifespan. During T cell priming, NK cells 
indirectly alter T cell responses by affecting DCs. Reciprocally, 
DCs are also able to modulate NK cells and this bidirectional 
interaction affects the emerging T cell response. More detailed 
insight into the detailed mechanisms of DC/NK interaction will 
be important to tailor T cell immunity in the context of vaccina-
tion or toleration.
The absence of NK cells induces alterations in the early phase 
of T cell responses, including direct attack of T cells. The detailed 
mechanisms of this direct regulation are, however, still being 
defined. Since NK cells are regulated via the net balance of sig-
nals perceived by their activating and inhibiting receptors, more 
insights into the regulation of NK receptor ligand expression on 
activated T cells is required.
Since T  cells have evolved several mechanisms to shield 
themselves against NK-mediated killing during early activation, 
a more detailed molecular understanding about this shielding 
process is important. Such knowledge might also be useful to 
understand whether and how autoreactive T cells can be rendered 
targets for NK cell attack.
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